Lv1
40 积分 2024-03-02 加入
Long-acting HIV fusion inhibitor albuvirtide combined with ritonavir-boosted lopinavir for HIV-1-infected patients after failing the first-line antiretroviral therapy: 48-week randomized, controlled, phase 3 non-inferiority TALENT study
1个月前
已完结
Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study
5个月前
已关闭
BRCC3 Regulation of ALK2 in Vascular Smooth Muscle Cells: Implication in Pulmonary Hypertension
6个月前
已完结
The Diagnosis and Treatment of COPD and Its Comorbidities
1年前
已完结
皖公网安备34019202002308
